ARTICLE | Clinical News

HEPH Phase II malaria results

November 12, 2001 8:00 AM UTC

Hollis- Eden (HEPH) said that in a Phase II study of HE2000 immune regulating hormone in Thailand, 19 of 21 patients met the primary endpoint of a 50% reduction in malaria parasite count after 7 days....